Among the CMA’s draft recommendations include calling on governments to clamp down on user fees to access primary care and restricting or eliminating ‘duplicative insurance models.’
Because any physician or nurse practitioner in Alberta can prescribe Mifegymiso, the medication has helped eliminate geographic barriers to services for patients in rural and remote communities.